Additional file 3: Table S8. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

Additional file 1: Table S1. of Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease

Michael Mosteller (3661939)
Maarten van den Berge (116456)
Louise Hosking (3661936)
Wim Timens (41871)
Pieter Hiemstra (3661933)
Courtney Crim (164955)
Dirkje Postma (3410420)
Soumitra Ghosh (21255)

January 2017

Clinical characteristics of patients with COPD by rs37973 genotype (Studies 1 and 2). Table S2. Clin...

Additional file 3: of Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

George Bardsley (5511125)
Janine Pilcher (5816717)
Steven McKinstry (808737)
Philippa Shirtcliffe (5816723)
James Berry (3481253)
James Fingleton (3728818)
Mark Weatherall (3198705)
Richard Beasley (239695)

October 2018

Online supplement - Table S1. PtCO2 change âĽ4Â mmHg according to randomised treatment. Table S2. S...

Additional file 4: Table S2. of Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD

Peter Calverley (3468770)
Stephen Rennard (204838)
Emmanuelle Clerisme-Beaty (3431258)
Norbert Metzdorf (3435299)
Valentina Zubek (3466802)
Richard ZuWallack (3486143)

March 2016

Pearsonâs correlation coefficients: night-time awakening scores and 36-item Short-Form Health Surv...

Additional file 4: Table S9. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Overview of inclusion and exclusion criteria of RCTs testing for RCTs testing other single treatment...

Additional file 2: Tables S1-S7. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Applied definitions of inclusion criteria in the Optimum Patient Care Research Database (OPCRD). Tab...

Additional file 3: Table S3. of Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Natalia Hawken (4231069)
Saku Torvinen (4231075)
Mohamed-Elmoctar Neine (4231072)
Ikbel Amri (4041179)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)
Adam Plich (4231078)
Nicolas Roche (113352)

July 2017

Patient demographics and clinical characteristics for COPD patients aged over 40 years old. (DOCX 14...

Additional file 1: Figure S1. of Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis

Fabiano Di Marco (3171375)
Giovanni Sotgiu (16787)
Pierachille Santus (4796115)
Denis OâDonnell (4796124)
Kai-Michael Beeh (3521786)
Simone Dore (4796118)
Maria Roggi (4796112)
Lisa Giuliani (4796109)
Francesco Blasi (61418)
Stefano Centanni (3171360)

January 2018

Funnel plots for ET, isotime IC and isotime dyspnea. Figure S2A Forest and Funnel plots of ET, isoti...

Additional file 5: Table S2. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses reporting proportions of patients achieving lung function improvements for...

Additional file 3: of Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial

Erin Davis (3439649)
Carlo Marra (305751)
John-Michael Gamble (3454946)
Jamie Farrell (3454940)
Joe Lockyer (3454949)
J. FitzGerald (3454952)
Waseem Abu-Ashour (3454943)
Charlie Gillis (3454937)
John Hawboldt (3454955)

October 2016

COPD refresher presentation. The training presentation used to refresh participating pharmacistsâ ...

Additional file 6: Table S3. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses of FVC other endpoints (selected) (ITT population). (DOC 43Â kb

Additional file 2: of Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial

Chin Rhee (3774220)
Hye Park (3485240)
Jeong-Woong Park (504862)
Ji-Hyun Lee (145976)
Tae-Hyung Kim (18097)
Sei Lee (3528461)
Ji Jung (3774187)
Song Kim (3503126)
Yong Hwang (3774223)
Ki-Suck Jung (2817685)

February 2017

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 2: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...

Additional file 1: of The COPD-SIB: a newly developed disease-specific item bank to measure health-related quality of life in patients with chronic obstructive pulmonary disease

Muirne Paap (3478190)
Lonneke Lenferink (3478196)
Nadine Herzog (3478199)
Karel Kroeze (3478193)
Job van der Palen (748057)

June 2016

Detailed explanation of Three Step Test Interview (TSTI) along with example probes. (PDF 92 kb

Additional file 1: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

List of institutions and Independent Ethics Committees/Institutional Review Boards for Study DB21161...

Additional file 1: of Association of lung function with cardiovascular risk: a cohort study

Bin Wang (30851)
Yun Zhou (308977)
Lili Xiao (3182601)
Yanjun Guo (446774)
Jixuan Ma (4526053)
Min Zhou (173135)
Tingming Shi (62627)
Aijun Tan (5939990)
Jing Yuan (217967)
Weihong Chen (170472)

November 2018

Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...

Additional file 1: Table S1. of Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease

Michael Mosteller (3661939)
Maarten van den Berge (116456)
Louise Hosking (3661936)
Wim Timens (41871)
Pieter Hiemstra (3661933)
Courtney Crim (164955)
Dirkje Postma (3410420)
Soumitra Ghosh (21255)

January 2017

Clinical characteristics of patients with COPD by rs37973 genotype (Studies 1 and 2). Table S2. Clin...

Additional file 3: of Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

George Bardsley (5511125)
Janine Pilcher (5816717)
Steven McKinstry (808737)
Philippa Shirtcliffe (5816723)
James Berry (3481253)
James Fingleton (3728818)
Mark Weatherall (3198705)
Richard Beasley (239695)

October 2018

Online supplement - Table S1. PtCO2 change âĽ4Â mmHg according to randomised treatment. Table S2. S...

Additional file 4: Table S2. of Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD

Peter Calverley (3468770)
Stephen Rennard (204838)
Emmanuelle Clerisme-Beaty (3431258)
Norbert Metzdorf (3435299)
Valentina Zubek (3466802)
Richard ZuWallack (3486143)

March 2016

Pearsonâs correlation coefficients: night-time awakening scores and 36-item Short-Form Health Surv...

Additional file 4: Table S9. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Overview of inclusion and exclusion criteria of RCTs testing for RCTs testing other single treatment...

Additional file 2: Tables S1-S7. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

David Halpin (93900)
Marjan Kerkhof (293935)
Joan Soriano (3472262)
Helga Mikkelsen (190701)
David Price (18505)

September 2016

Applied definitions of inclusion criteria in the Optimum Patient Care Research Database (OPCRD). Tab...

Additional file 3: Table S3. of Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment

Natalia Hawken (4231069)
Saku Torvinen (4231075)
Mohamed-Elmoctar Neine (4231072)
Ikbel Amri (4041179)
Mondher Toumi (46017)
Samuel AballĂŠa (4231090)
Adam Plich (4231078)
Nicolas Roche (113352)

July 2017

Patient demographics and clinical characteristics for COPD patients aged over 40 years old. (DOCX 14...

Additional file 1: Figure S1. of Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis

Fabiano Di Marco (3171375)
Giovanni Sotgiu (16787)
Pierachille Santus (4796115)
Denis OâDonnell (4796124)
Kai-Michael Beeh (3521786)
Simone Dore (4796118)
Maria Roggi (4796112)
Lisa Giuliani (4796109)
Francesco Blasi (61418)
Stefano Centanni (3171360)

January 2018

Funnel plots for ET, isotime IC and isotime dyspnea. Figure S2A Forest and Funnel plots of ET, isoti...

Additional file 5: Table S2. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses reporting proportions of patients achieving lung function improvements for...

Additional file 3: of Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial

Erin Davis (3439649)
Carlo Marra (305751)
John-Michael Gamble (3454946)
Jamie Farrell (3454940)
Joe Lockyer (3454949)
J. FitzGerald (3454952)
Waseem Abu-Ashour (3454943)
Charlie Gillis (3454937)
John Hawboldt (3454955)

October 2016

COPD refresher presentation. The training presentation used to refresh participating pharmacistsâ ...

Additional file 6: Table S3. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Results from the analyses of FVC other endpoints (selected) (ITT population). (DOC 43Â kb

Additional file 2: of Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial

Chin Rhee (3774220)
Hye Park (3485240)
Jeong-Woong Park (504862)
Ji-Hyun Lee (145976)
Tae-Hyung Kim (18097)
Sei Lee (3528461)
Ji Jung (3774187)
Song Kim (3503126)
Yong Hwang (3774223)
Ki-Suck Jung (2817685)

February 2017

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 2: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...

Additional file 1: of The COPD-SIB: a newly developed disease-specific item bank to measure health-related quality of life in patients with chronic obstructive pulmonary disease

Muirne Paap (3478190)
Lonneke Lenferink (3478196)
Nadine Herzog (3478199)
Karel Kroeze (3478193)
Job van der Palen (748057)

June 2016

Detailed explanation of Three Step Test Interview (TSTI) along with example probes. (PDF 92 kb

Additional file 1: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

List of institutions and Independent Ethics Committees/Institutional Review Boards for Study DB21161...

Additional file 1: of Association of lung function with cardiovascular risk: a cohort study

Bin Wang (30851)
Yun Zhou (308977)
Lili Xiao (3182601)
Yanjun Guo (446774)
Jixuan Ma (4526053)
Min Zhou (173135)
Tingming Shi (62627)
Aijun Tan (5939990)
Jing Yuan (217967)
Weihong Chen (170472)

November 2018

Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...

Additional file 1: Table S1. of Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease

Michael Mosteller (3661939)
Maarten van den Berge (116456)
Louise Hosking (3661936)
Wim Timens (41871)
Pieter Hiemstra (3661933)
Courtney Crim (164955)
Dirkje Postma (3410420)
Soumitra Ghosh (21255)

January 2017

Clinical characteristics of patients with COPD by rs37973 genotype (Studies 1 and 2). Table S2. Clin...

Additional file 3: of Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

George Bardsley (5511125)
Janine Pilcher (5816717)
Steven McKinstry (808737)
Philippa Shirtcliffe (5816723)
James Berry (3481253)
James Fingleton (3728818)
Mark Weatherall (3198705)
Richard Beasley (239695)

October 2018

Online supplement - Table S1. PtCO2 change âĽ4Â mmHg according to randomised treatment. Table S2. S...

Additional file 4: Table S2. of Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD

Peter Calverley (3468770)
Stephen Rennard (204838)
Emmanuelle Clerisme-Beaty (3431258)
Norbert Metzdorf (3435299)
Valentina Zubek (3466802)
Richard ZuWallack (3486143)

March 2016

Pearsonâs correlation coefficients: night-time awakening scores and 36-item Short-Form Health Surv...

Additional file 3: Table S8. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

Abstract

Extracted data

Additional file 3: Table S8. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

Abstract

Extracted data

Related items

Related items